MoneyWorks4Me

Tatva Chintan Pharma - Quaterly Results

25 Oct 2024 Evaluate
The sales declined to Rs. 809.60 millions for the September 2024 quarter as compared to Rs. 925.73 millions during the corresponding quarter last year.The Net Loss for the quarter ended September 2024 is Rs. -11.11 millions as compared to Net Profit of Rs. 82.03 millions of corresponding quarter ended September 2023The Operating Profit of the company witnessed a decrease to 54.06 millions from 214.97 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 809.60 925.73 -12.54 1747.68 1986.78 -12.03 3786.77 4030.44 -6.05
Other Income 8.06 7.56 6.61 22.26 17.71 25.69 75.08 56.78 32.23
PBIDT 54.06 214.97 -74.85 145.21 421.25 -65.53 743.73 603.56 23.22
Interest 1.72 30.14 -94.29 4.86 59.12 -91.78 65.07 83.84 -22.39
PBDT 52.34 184.83 -71.68 140.35 362.13 -61.24 678.66 483.85 40.26
Depreciation 68.11 67.76 0.52 134.75 127.87 5.38 256.01 95.54 167.96
PBT -15.77 117.07 -113.47 5.60 234.26 -97.61 422.65 388.31 8.84
TAX -4.66 35.04 -113.30 1.63 69.75 -97.66 129.17 -16.34 -890.51
Deferred Tax -1.78 16.48 -110.80 0.91 30.79 -97.04 55.74 -35.93 -255.13
PAT -11.11 82.03 -113.54 3.97 164.51 -97.59 293.48 404.65 -27.47
Equity 233.92 233.92 0.00 233.92 233.92 0.00 233.92 221.65 5.54
PBIDTM(%) 6.68 23.22 -71.24 8.31 21.20 -60.81 19.64 14.98 31.15
Peers
Company Name CMP
Godrej Industries 1085.75
SRF 2483.95
BASF India 3482.30
Pidilite Inds. 1486.05
Tata Chemicals 628.60
View more..